🔬
Foundation Sciences · Embryology
Respiratory Development
Respiratory development begins in the fourth week with the formation of the respiratory diverticulum from the foregut. Development proceeds through four main stages: pseudoglandular, canalicular, saccular, and alveolar. A critical milestone is the production of surfactant by Type II pneumocytes around week 24, which allows for extrauterine lung function and prevents respiratory distress syndrome.
📌 Learning Objectives
- Describe the sequential stages of respiratory system development from the foregut bud to mature alveoli.
- Explain the critical role of surfactant in preventing alveolar collapse and its clinical significance.
- Identify common congenital anomalies of the respiratory system and their embryological origins.
- Apply knowledge of lung development to understand the pathophysiology of Respiratory Distress Syndrome (RDS).
📋 Overview
Understanding respiratory development is crucial for interpreting congenital anomalies, predicting neonatal outcomes, and managing conditions like Respiratory Distress Syndrome (RDS). It's a high-yield area for SBAs on prematurity and congenital malformations. Key concepts include the stages of lung maturation, the role of surfactant, and common developmental defects like Tracheoesophageal Fistula (TEF) and pulmonary hypoplasia.
🔬 Basic Science
The respiratory diverticulum's branching morphogenesis is driven by complex interactions between the endodermal epithelium and the surrounding mesenchyme. Type II pneumocytes are responsible for synthesising and secreting surfactant, a lipoprotein complex that reduces alveolar surface tension, preventing atelectasis (alveolar collapse) during expiration. Without adequate surfactant, the work of breathing is dramatically increased, leading to RDS. The historical Lecithin/Sphingomyelin (L/S) ratio in amniotic fluid assessed lung maturity; a ratio >2:1 indicated sufficient surfactant for extrauterine life.
🏥 Clinical Relevance
Tracheoesophageal fistula (TEF) often presents with polyhydramnios on antenatal ultrasound (due to inability to swallow amniotic fluid) and postnatally with choking, coughing, cyanosis during feeds, and inability to pass a nasogastric tube. Respiratory Distress Syndrome (RDS) is a major cause of morbidity and mortality in premature infants due to surfactant deficiency, leading to stiff, non-compliant lungs. Congenital Diaphragmatic Hernia (CDH) allows abdominal contents to herniate into the thoracic cavity, severely restricting lung growth and causing pulmonary hypoplasia, often with significant pulmonary hypertension. Understanding developmental stages helps predict the viability of extreme preterm infants and guides management strategies.
🧪 Investigations
Prenatal ultrasound can identify polyhydramnios (suggesting TEF/oesophageal atresia) or a diaphragmatic hernia (CDH). Postnatally, a chest X-ray in RDS typically shows a characteristic 'ground-glass' appearance with air bronchograms, indicating diffuse atelectasis and fluid-filled airways. The inability to pass a nasogastric tube into the stomach is a key diagnostic sign for oesophageal atresia, often associated with TEF.
💊 Management
Neonatal RDS is managed with exogenous surfactant and respiratory support (CPAP or ventilation). Antenatal corticosteroids are standard for threatened preterm labour between 24 and 34 weeks. CDH and TEF require urgent surgical repair.
Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.
MLA High-Yield Notes & Quick Revision ⌄
Remember the key milestone: surfactant production starts around 24 weeks. This is why babies born before this are at very high risk of RDS. The stages of lung development are often tested: Pseudoglandular, Canalicular, Saccular, Alveolar (Mnemonic: 'Please Can Some Air'). TEF is a classic SBA question, often linked to the VACTERL association (Vertebral defects, Anal atresia, Cardiac defects, Tracheoesophageal fistula, Renal anomalies, Limb defects). Be ready to discuss the role of antenatal steroids in preterm labour – they accelerate lung maturation. For OSCEs, know how to recognise signs of respiratory distress in a neonate and the initial management steps.
Neonatal respiratory distress
Congenital anomalies of the respiratory system
Prematurity complications
Dyspnoea in neonates
- Week 4: Respiratory diverticulum forms from foregut.
- Pseudoglandular stage (5-16 weeks): Branching, no gas exchange.
- Canalicular stage (16-26 weeks): Respiratory bronchioles, vascularisation, primitive alveoli.
- Saccular stage (26-36 weeks): Terminal sacs (primitive alveoli) form.
- Alveolar stage (36 weeks-8 years): Mature alveoli develop, significant increase in number.
- Type II pneumocytes produce surfactant from ~week 24.
Exam Pearls ⌄
⭐ High Yield
Respiratory development begins in week 4 with the laryngotracheal groove forming from the ventral foregut endoderm.
The four main stages of lung development are pseudoglandular, canalicular, saccular, and alveolar.
Surfactant production by Type II pneumocytes starts around week 20, becoming clinically significant by week 24.
Tracheoesophageal fistula (TEF) results from incomplete separation of the foregut into oesophagus and trachea.
Pulmonary hypoplasia is often associated with conditions limiting thoracic space or amniotic fluid volume (e.g., congenital diaphragmatic hernia, oligohydramnios).
The pseudoglandular stage (weeks 5-16) involves branching but no gas exchange structures.
The canalicular stage (weeks 16-26) is marked by the formation of respiratory bronchioles and primitive alveoli, and vascularisation.
💡 Clinical Pearl
Respiratory Distress Syndrome (RDS): Premature infants lack sufficient surfactant, leading to alveolar collapse and severe breathing difficulties.
Tracheoesophageal Fistula (TEF): An abnormal connection between the trachea and oesophagus, often presenting with feeding difficulties and aspiration in neonates.
Congenital Diaphragmatic Hernia (CDH): Herniation of abdominal contents into the thorax restricts lung growth, leading to pulmonary hypoplasia.
Pulmonary Hypoplasia: Underdevelopment of the lungs, often secondary to other conditions like oligohydramnios or thoracic space-occupying lesions.
⚠️ Exam Tip — Common Mistakes
Confusing the order or key features of the lung development stages.
Underestimating the importance of surfactant and Type II pneumocytes.
Attributing all neonatal respiratory distress solely to prematurity without considering structural anomalies.
Forgetting that the respiratory diverticulum is an outgrowth of the foregut.
Key Facts ⌄
The lung bud originates from the ventral foregut endoderm (epithelial lining) and surrounding splanchnic mesoderm (connective tissue, muscle, cartilage).
Surfactant production by Type II pneumocytes begins around 24 weeks gestation, making this a critical viability milestone.
Tracheoesophageal fistula (TEF) and oesophageal atresia are the most common congenital anomalies, often presenting with polyhydramnios and neonatal feeding difficulties.
Oligohydramnios (low amniotic fluid) can severely impair lung development, leading to pulmonary hypoplasia, as fetal breathing movements are essential for lung growth.
Antenatal corticosteroids (e.g., Betamethasone) are given to mothers in threatened preterm labour to accelerate fetal lung maturation and surfactant production.
Alveolar development continues significantly postnatally, with most mature alveoli forming up to age 8.
Related Topics ⌄
References ⌄
- TeachMeAnatomy - Development of the Lungs
- NICE CKS: Preterm labour
- TeachMePhysiology - Lung Volumes
Further Resources
Medical Portfolio & Career Development
Build a professional portfolio website for applications, audits, teaching, research and career progression.
CVtoWebsite.com →